AAAAAA

   
Results: 1-10 |
Results: 10
ANALYSIS OF IN-VITRO LYMPHOCYTE ADHESION AND TRANSENDOTHELIAL MIGRATION BY FLUORESCENT-BEADS-BASED FLOW CYTOMETRIC CELL COUNTING
Authors: MOLEMA G MESANDER G KROESEN BJ HELFRICH W MEIJER DKF DELEIJ LFMH
Citation: G. Molema et al., ANALYSIS OF IN-VITRO LYMPHOCYTE ADHESION AND TRANSENDOTHELIAL MIGRATION BY FLUORESCENT-BEADS-BASED FLOW CYTOMETRIC CELL COUNTING, Cytometry, 32(1), 1998, pp. 37-43
BISPECIFIC ANTIBODIES FOR TREATMENT OF CANCER IN EXPERIMENTAL ANIMAL-MODELS AND MAN
Authors: KROESEN BJ HELFRICH W MOLEMA G DELEIJ L
Citation: Bj. Kroesen et al., BISPECIFIC ANTIBODIES FOR TREATMENT OF CANCER IN EXPERIMENTAL ANIMAL-MODELS AND MAN, Advanced drug delivery reviews, 31(1-2), 1998, pp. 105-129
CONSTRUCTION AND CHARACTERIZATION OF A BISPECIFIC DIABODY FOR RETARGETING T-CELLS TO HUMAN CARCINOMAS
Authors: HELFRICH W KROESEN BJ ROOVERS RC WESTERS L MOLEMA G HOOGENBOOM HR DELEIJ L
Citation: W. Helfrich et al., CONSTRUCTION AND CHARACTERIZATION OF A BISPECIFIC DIABODY FOR RETARGETING T-CELLS TO HUMAN CARCINOMAS, International journal of cancer, 76(2), 1998, pp. 232-239
APPROACHES TO LUNG-CANCER TREATMENT USING THE CD3E-X-GP-2-DIRECTED BISPECIFIC MONOCLONAL-ANTIBODY BIS-1
Authors: KROESEN BJ NIEKEN J SLEIJFER DT MOLEMA G DEVRIES EGE GROEN HJM HELFRICH W THE TH MULDER NH DELEIJ L
Citation: Bj. Kroesen et al., APPROACHES TO LUNG-CANCER TREATMENT USING THE CD3E-X-GP-2-DIRECTED BISPECIFIC MONOCLONAL-ANTIBODY BIS-1, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 203-206
THE ROLE OF APOPTOSIS IN BISPECIFIC ANTIBODY-MEDIATED T-CELL CYTOTOXICITY
Authors: KROESEN BJ WELLENBERG GJ BAKKER A HELFRICH W THE TH DELEIJ L
Citation: Bj. Kroesen et al., THE ROLE OF APOPTOSIS IN BISPECIFIC ANTIBODY-MEDIATED T-CELL CYTOTOXICITY, British Journal of Cancer, 73(6), 1996, pp. 721-727
REDUCTION OF EGP-2-POSITIVE PULMONARY METASTASES BY BISPECIFIC-ANTIBODY-REDIRECTED T-CELLS IN AN IMMUNOCOMPETENT RAT MODEL
Authors: KROESEN BJ HELFRICH W BAKKER A WUBBENA AS BAKKER H KAL HB THE TH DELEIJ L
Citation: Bj. Kroesen et al., REDUCTION OF EGP-2-POSITIVE PULMONARY METASTASES BY BISPECIFIC-ANTIBODY-REDIRECTED T-CELLS IN AN IMMUNOCOMPETENT RAT MODEL, International journal of cancer, 61(6), 1995, pp. 812-818
BISPECIFIC ANTIBODY-MEDIATED TARGET CELL-SPECIFIC COSTIMULATION OF RESTING T-CELLS VIA CD5 AND CD28
Authors: KROESEN BJ BAKKER A VANLIER RAW THE HT DELEIJ L
Citation: Bj. Kroesen et al., BISPECIFIC ANTIBODY-MEDIATED TARGET CELL-SPECIFIC COSTIMULATION OF RESTING T-CELLS VIA CD5 AND CD28, Cancer research, 55(19), 1995, pp. 4409-4415
IMMUNOMODULATORY EFFECTS OF INTRAVENOUS BIS-1 F(AB')(2) ADMINISTRATION IN RENAL-CELL CANCER-PATIENTS
Authors: JANSSEN RAJ KROESEN BJ BUTER J MESANDER G SLEIJFER DT THE TH MULDER NH DELEIJ L
Citation: Raj. Janssen et al., IMMUNOMODULATORY EFFECTS OF INTRAVENOUS BIS-1 F(AB')(2) ADMINISTRATION IN RENAL-CELL CANCER-PATIENTS, British Journal of Cancer, 72(3), 1995, pp. 795-799
PHASE-I STUDY OF INTRAVENOUSLY APPLIED BISPECIFIC ANTIBODY IN RENAL-CELL CANCER-PATIENTS RECEIVING SUBCUTANEOUS INTERLEUKIN-2
Authors: KROESEN BJ BUTER J SLEIJFER DT JANSSEN RAJ VANDERGRAAF WTA THE TH DELEIJ L MULDER NH
Citation: Bj. Kroesen et al., PHASE-I STUDY OF INTRAVENOUSLY APPLIED BISPECIFIC ANTIBODY IN RENAL-CELL CANCER-PATIENTS RECEIVING SUBCUTANEOUS INTERLEUKIN-2, British Journal of Cancer, 70(4), 1994, pp. 652-661
LOCAL ANTITUMOR TREATMENT IN CARCINOMA PATIENTS WITH BISPECIFIC-MONOCLONAL-ANTIBODY-REDIRECTED T-CELLS
Authors: KROESEN BJ TERHAAR A SPAKMAN H WILLEMSE P SLEIJFER DT DEVRIES EGE MULDER NH BERENDSEN HH LIMBURG PC THE TH DELEIJ L
Citation: Bj. Kroesen et al., LOCAL ANTITUMOR TREATMENT IN CARCINOMA PATIENTS WITH BISPECIFIC-MONOCLONAL-ANTIBODY-REDIRECTED T-CELLS, Cancer immunology and immunotherapy, 37(6), 1993, pp. 400-407
Risultati: 1-10 |